Skip to product information
1 of 1

BioPeptics

BPC-157 - 10 mg (Body Protection Compound-157)

BPC-157 - 10 mg (Body Protection Compound-157)

Regular price R 1,200.00
Regular price Sale price R 1,200.00
Sale Sold out
Quantity

BPC-157 is a synthetic peptide fragment derived from the naturally occurring Body Protection Compound found in gastric fluid. It is widely studied for its potential roles in tissue regeneration, injury recovery, inflammation modulation, and gastrointestinal support.
The Biopeptics BPC-157 vial is provided in lyophilized powder form for enhanced stability and purity suitable for advanced research applications in regenerative and experimental models.

For research use only. 

How It Works

1. Tissue Regeneration & Cellular Repair

BPC-157 is best known for its ability to support healing in a wide range of tissues. Research demonstrates:

  • Accelerated tendon, ligament, and muscle repair
  • Enhanced angiogenesis (formation of new blood vessels)
  • Improved fibroblast activity and collagen organization
  • Reduced scar formation and improved tissue alignment

These effects make it a core molecule in injury-recovery and musculoskeletal research.

2. Anti-Inflammatory Modulation

In experimental models, BPC-157 has been shown to:

  • Reduce inflammatory cytokines
  • Improve microcirculation in damaged tissues
  • Protect against oxidative stress
  • Balance nitric-oxide pathways for improved healing

This anti-inflammatory profile supports research in systemic or localized inflammation.

3. Gastrointestinal Protection

BPC-157 originates from gastric proteins and plays a notable role in gut integrity. Studies show it may:

  • Enhance mucosal lining repair
  • Protect against NSAID-induced gastric lesions
  • Improve gastric-motility signaling
  • Promote intestinal barrier strength

These traits are valuable in gastrointestinal and ulcer-repair models.

4. Neurological & Vascular Effects

Research indicates BPC-157 may support:

  • Neuroprotection following injury
  • Improved peripheral nerve healing
  • Enhanced vascular response and circulation

Its multi-system interactions extend its use across regenerative and experimental neuroscience studies.

Research Applications

  • Tendon, ligament, and muscle healing studies
  • Systemic inflammation and recovery models
  • Gastrointestinal healing and mucosal protection
  • Nerve regeneration research
  • Tissue repair and angiogenesis studies

Composition

BPC-157 – 10 mg Lyophilized Peptide Powder

Dosage Guidance

BPC-157 — Research Dosage Guidance
Reconstitution (Mixing)

  • Add 2 ml Bacteriostatic Water to the vial
  • Roll gently between palms (do not shake)
  • Store reconstituted vial in the refrigerator (2–8 °C)

Concentration Calculation

10 mg ÷ 2 ml = 5 mg/ml

Every 10 insulin units (0.1 ml) = 0.5 mg (500 mcg)

Core Research Dosage Guidelines

For tissue repair, injury recovery, inflammation modulation, and gastrointestinal research

Standard protocol: 300–500 mcg per injection

Frequency: 1–2× daily

Advanced protocol: 500–750 mcg twice daily

Administration: Subcutaneous or intramuscular micro-injection

Injection sites: Rotate regularly

Dose Conversion Table

Dose    Volume    Insulin Units

300 mcg    0.06 ml    6 units
500 mcg    0.10 ml    10 units
750 mcg    0.15 ml    15 units
1 mg    0.20 ml    20 units

Targeted Research Protocols
1.⁠ ⁠Acute Injury & Tissue Repair

  • (Strains, tears, post-procedure recovery)
  • Dose: 500–750 mcg
  • Frequency: Twice daily
  • Timing: Morning + evening
  • Duration: 4–6 weeks
  • Notes: IM near affected area or SC systemic dosing

2.⁠ ⁠Chronic Pain, Inflammation & Overuse

  • (Tendinitis, joint stress, repetitive strain)
  • Dose: 300–500 mcg
  • Frequency: 1–2× daily
  • Duration: 6–8 weeks
  • Notes: Rotate sites; consistency is key

3.⁠ ⁠Gastrointestinal & Gut-Barrier Research

  • (IBS-like models, mucosal integrity, inflammation)
  • Dose: 250–500 mcg
  • Frequency: Once daily (evening preferred)
  • Duration: 4–8 weeks
  • Notes: Subcutaneous administration recommended

4.⁠ ⁠Post-Surgical / Intensive Recovery Models

  • Dose: 750 mcg
  • Frequency: Twice daily
  • Duration: 6–8 weeks
  • Notes: Higher dosing reserved for advanced research protocols

5.⁠ ⁠Maintenance / Preventative Research

  • Dose: 250–300 mcg
  • Frequency: 3–5 days per week
  • Duration: Ongoing as required
  • Notes: Suitable after completing a full cycle

Cycle Duration

  • Typical cycle: 4–8 weeks
  • Extended cycle: Up to 12 weeks
  • Maintenance: 3–5 days per week as needed

Key Research Benefits

  • Supports tendon, ligament, muscle, and soft-tissue repair
  • Promotes anti-inflammatory and cytoprotective effects
  • May support gastrointestinal lining integrity
  • Assists recovery from strain, repetitive stress, and injury
  • Well-documented peptide in regenerative research models

Important Notes

Always use sterile needles and alcohol swabs

Do not reuse or share needles

Store reconstituted peptide at 2–8 °C

For research use only

Possible Side Effects (Observed in Research & Clinical Settings)

Who Should Use with Caution / Avoid in Research Contexts

BPC-157 is a regenerative peptide that promotes angiogenesis, tissue repair, and gastrointestinal mucosal healing. Use caution or avoid in the following research contexts:

Active malignancy or tumor-bearing models (angiogenic and regenerative signaling may influence outcomes)

Severe or unstable cardiovascular disease models (vascular modulation may affect hemodynamic parameters)

Pregnancy or lactation models (no safety data available)

Hypotension-prone models (may influence vascular tone or blood pressure)

Gastrointestinal tumors, dysplasia, or proliferative GI abnormalities (may enhance regenerative signaling and confound results)

Summary

BPC-157 is one of the most extensively researched regenerative peptides, valued for its tissue-repair, anti-inflammatory, and gut-protective properties. It demonstrates broad utility across musculoskeletal, vascular, and gastrointestinal research models. Side effects are generally mild and transient, commonly presenting as slight fatigue or localized injection-site irritation. Proper dilution and controlled administration enhance consistency and minimize discomfort in research settings.

View full details